{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:19:32Z","timestamp":1780391972209,"version":"3.54.1"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03384-9","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:14:20Z","timestamp":1775675660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Modalities for Cataract Management: Preventive, Surgical, and Non-Surgical Approaches Using Conventional and Nanotechnology-Based Therapies"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1176-575X","authenticated-orcid":false,"given":"Aya","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5433-5207","authenticated-orcid":false,"given":"Maha","family":"El-Kayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7635-6842","authenticated-orcid":false,"given":"Rehab Nabil","family":"Shamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4235-669X","authenticated-orcid":false,"given":"Asmaa F.","family":"Khafaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5105-3669","authenticated-orcid":false,"given":"Nihal Farid","family":"Younes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"3384_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212368","volume":"22","author":"A Vaneev","year":"2021","unstructured":"Vaneev A, Tikhomirova V, Chesnokova N, Popova E, Beznos O, Kost O, et al. Nanotechnology for topical drug delivery to the anterior segment of the eye. Int J Mol Sci. 2021;22:12368. https:\/\/doi.org\/10.3390\/ijms222212368.","journal-title":"Int J Mol Sci"},{"key":"3384_CR2","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/mjt.0b013e3181ea31ff","volume":"23","author":"MA Babizhayev","year":"2016","unstructured":"Babizhayev MA, Yegorov YE. Reactive oxygen species and the aging eye: specific role of metabolically active mitochondria in maintaining lens function and in the initiation of the oxidation-induced maturity onset cataract\u2014a novel platform of mitochondria-targeted antioxidants with b. Am J Ther. 2016;23:e98\u2013117. https:\/\/doi.org\/10.1097\/mjt.0b013e3181ea31ff.","journal-title":"Am J Ther"},{"key":"3384_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12071379","volume":"12","author":"N Kushwah","year":"2023","unstructured":"Kushwah N, Bora K, Maurya M, Pavlovich MC, Chen J. Oxidative stress and antioxidants in age-related macular degeneration. Antioxidants. 2023;12:1379. https:\/\/doi.org\/10.3390\/antiox12071379.","journal-title":"Antioxidants"},{"key":"3384_CR4","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.3390\/ijms24076317","volume":"24","author":"M Mrugacz","year":"2023","unstructured":"Mrugacz M, Pony-Uram M, Bryl A, Zorena K. Current approach to the pathogenesis of diabetic cataracts. Int J Mol Sci. 2023;24:6317. https:\/\/doi.org\/10.3390\/ijms24076317.","journal-title":"Int J Mol Sci"},{"key":"3384_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12123651","volume":"12","author":"A Hilliard","year":"2020","unstructured":"Hilliard A, Mendonca P, Russell TD, Soliman KFA. The protective effects of flavonoids in cataract formation through the activation of Nrf2 and the inhibition of MMP-9. Nutrients. 2020;12:1\u201322. https:\/\/doi.org\/10.3390\/nu12123651.","journal-title":"Nutrients"},{"key":"3384_CR6","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.ophtha.2015.06.052","volume":"122","author":"J Chua","year":"2015","unstructured":"Chua J, Koh JY, Tan AG, Zhao W, Lamoureux E, Mitchell P, et al. Ancestry, Socioeconomic Status, and Age-Related Cataract in Asians: The Singapore Epidemiology of Eye Diseases Study. Ophthalmology. 2015;122:2169\u201378. https:\/\/doi.org\/10.1016\/j.ophtha.2015.06.052.","journal-title":"Ophthalmology"},{"key":"3384_CR7","doi-asserted-by":"publisher","DOI":"10.18203\/2394-6040.ijcmph20232663","volume":"10","author":"MA Adeniyi","year":"2023","unstructured":"Adeniyi MA, Adewoye RK, Popoola GO, Aderukuola B, Ibrahim AO, Azees AS. Awareness, prevalence and risk burden of cataract among adults in IDO\/OSI local government area, a rural community of Ekiti state, southwest Nigeria. Int J Community Med Public Health. 2023;10:3077. https:\/\/doi.org\/10.18203\/2394-6040.ijcmph20232663.","journal-title":"Int J Community Med Public Health"},{"key":"3384_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14491-0","volume":"22","author":"R Fang","year":"2022","unstructured":"Fang R, Yu Y-F, Li E-J, Lv N-X, Liu Z-C, Zhou H-G, et al. Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019. BMC Public Health. 2022;22:2068. https:\/\/doi.org\/10.1186\/s12889-022-14491-0.","journal-title":"BMC Public Health"},{"key":"3384_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biom14091055","volume":"14","author":"M Kulbay","year":"2024","unstructured":"Kulbay M, Wu KY, Nirwal GK, B\u00e9langer P, Tran SD. Oxidative stress and cataract formation: evaluating the efficacy of antioxidant therapies. Biomolecules. 2024;14:1055. https:\/\/doi.org\/10.3390\/biom14091055.","journal-title":"Biomolecules"},{"key":"3384_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.aopr.2023.10.001","volume":"3","author":"Z Guo","year":"2023","unstructured":"Guo Z, Ma X, Zhang RX, Yan H. Oxidative stress, epigenetic regulation and pathological processes of lens epithelial cells underlying diabetic cataract. Adv Ophthalmol Pract Res. 2023;3:180\u20136. https:\/\/doi.org\/10.1016\/j.aopr.2023.10.001.","journal-title":"Adv Ophthalmol Pract Res"},{"key":"3384_CR11","doi-asserted-by":"publisher","DOI":"10.1201\/9780429289323","volume-title":"Cellular antioxidant defense mechanisms","author":"CK Chow","year":"2019","unstructured":"Chow CK. Cellular antioxidant defense mechanisms. CRC Press; 2019. https:\/\/doi.org\/10.1201\/9780429289323."},{"key":"3384_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/15321819.2020.1726774","volume":"41","author":"A Ahmad","year":"2020","unstructured":"Ahmad A, Ahsan H. Biomarkers of inflammation and oxidative stress in ophthalmic disorders. J Immunoassay Immunochem. 2020;41:257\u201371. https:\/\/doi.org\/10.1080\/15321819.2020.1726774.","journal-title":"J Immunoassay Immunochem"},{"key":"3384_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamaophthalmol.2013.6241","volume":"132","author":"S Rautiainen","year":"2014","unstructured":"Rautiainen S, Lindblad BE, Morgenstern R, Wolk A. Total antioxidant capacity of the diet and risk of age-related cataract: a population-based prospective cohort of women. JAMA Ophthalmol. 2014;132:247\u201352. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.6241.","journal-title":"JAMA Ophthalmol"},{"key":"3384_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/ajcn\/nqz167","volume":"110","author":"AG Tan","year":"2019","unstructured":"Tan AG, Kifley A, Flood VM, Holliday EG, Scott RJ, Cumming RG, et al. Evaluating the associations between obesity and age-related cataract: a Mendelian randomization study. Am J Clin Nutr. 2019;110:969\u201376. https:\/\/doi.org\/10.1093\/ajcn\/nqz167.","journal-title":"Am J Clin Nutr"},{"key":"3384_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/07853890.2021.1928275","volume":"53","author":"D Jee","year":"2021","unstructured":"Jee D, Park SH, Hwang HS, Kim HS, Kim MS, Kim EC. Effects of hormone replacement therapy on lens opacity, serum inflammatory cytokines, and antioxidant levels. Ann Med. 2021;53:707\u201314. https:\/\/doi.org\/10.1080\/07853890.2021.1928275.","journal-title":"Ann Med"},{"key":"3384_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ph13010015","author":"SH Heruye","year":"2020","unstructured":"Heruye SH, Nkenyi LNM, Singh NU, Yalzadeh D, Ngele KK, Njie-Mbye YF, et al. Current trends in the pharmacotherapy of cataracts. Pharmaceuticals. 2020. https:\/\/doi.org\/10.3390\/ph13010015.","journal-title":"Pharmaceuticals"},{"key":"3384_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.52711\/2231-5691.2024.00012","volume":"14","author":"VP More","year":"2024","unstructured":"More VP, Jagtap PN, Musale SK, Kadam AM, Bobade SS, Pol KD. Pathophysiology, diagnosis and management of cataract. Asian J Pharm Res. 2024;14:77\u201382. https:\/\/doi.org\/10.52711\/2231-5691.2024.00012.","journal-title":"Asian J Pharm Res"},{"key":"3384_CR18","doi-asserted-by":"publisher","unstructured":"K. Christina, S. Martina, G. Panayotou, D.S. Papaconstantinou, M.M. Moschos, Lens Cytoskeleton: An Update on the Etiopathogenesis of Human Cataracts, Cureus. 16 (2024). https:\/\/doi.org\/10.7759\/cureus.56793.","DOI":"10.7759\/cureus.56793"},{"key":"3384_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.pbiomolbio.2003.11.012","volume":"86","author":"H Bloemendal","year":"2004","unstructured":"Bloemendal H, De Jong W, Jaenicke R, Lubsen NH, Slingsby C, Tardieu A. Ageing and vision: structure, stability and function of lens crystallins. Prog Biophys Mol Biol. 2004;86:407\u201385. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2003.11.012.","journal-title":"Prog Biophys Mol Biol"},{"key":"3384_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/membranes11060447","volume":"11","author":"R Timsina","year":"2021","unstructured":"Timsina R, Mainali L. Association of alpha-crystallin with fiber cell plasma membrane of the eye lens accompanied by light scattering and cataract formation. Membranes. 2021;11:447. https:\/\/doi.org\/10.3390\/membranes11060447.","journal-title":"Membranes"},{"key":"3384_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108709","volume":"210","author":"TFL Wishart","year":"2021","unstructured":"Wishart TFL, Flokis M, Shu DY, Das SJ, Lovicu FJ. Hallmarks of lens aging and cataractogenesis. Exp Eye Res. 2021;210:108709. https:\/\/doi.org\/10.1016\/j.exer.2021.108709.","journal-title":"Exp Eye Res"},{"key":"3384_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13020187","author":"DY Shu","year":"2023","unstructured":"Shu DY, Chaudhary S, Cho K-S, Lennikov A, Miller WP, Thorn DC, et al. Role of oxidative stress in ocular diseases: a balancing act. Metabolites. 2023. https:\/\/doi.org\/10.3390\/metabo13020187.","journal-title":"Metabolites"},{"key":"3384_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.12816\/0042978","volume":"70","author":"AZ Alshamrani","year":"2018","unstructured":"Alshamrani AZ. Cataracts pathophysiology and managements. Egypt J Hosp Med. 2018;70:151\u20134. https:\/\/doi.org\/10.12816\/0042978.","journal-title":"Egypt J Hosp Med"},{"key":"3384_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jflm.2012.05.002","volume":"20","author":"C Moreschi","year":"2013","unstructured":"Moreschi C, Da Broi U, Lanzetta P. Medico-legal implications of traumatic cataract. J Forensic Leg Med. 2013;20:69\u201373. https:\/\/doi.org\/10.1016\/j.jflm.2012.05.002.","journal-title":"J Forensic Leg Med"},{"key":"3384_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/0301-4738.121141","volume":"62","author":"V Gupta","year":"2014","unstructured":"Gupta V, Rajagopala M, Ravishankar B. Etiopathogenesis of cataract: an appraisal. Indian J Ophthalmol. 2014;62:103\u201310. https:\/\/doi.org\/10.4103\/0301-4738.121141.","journal-title":"Indian J Ophthalmol"},{"key":"3384_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jcjo.2021.02.022","volume":"56","author":"G de Garc\u00eda Oteyza","year":"2021","unstructured":"de Garc\u00eda Oteyza G, Garc\u00eda-Albisua AM. Shield-shaped cataract in severe atopic dermatitis. Can J Ophthalmol. 2021;56:396. https:\/\/doi.org\/10.1016\/j.jcjo.2021.02.022.","journal-title":"Can J Ophthalmol"},{"key":"3384_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5114\/ada.2018.79445","volume":"104","author":"JI Hsu","year":"2019","unstructured":"Hsu JI, Pflugfelder SC, Kim SJ. Ocular complications of atopic dermatitis. Cutis. 2019;104:189\u201393. https:\/\/doi.org\/10.5114\/ada.2018.79445.","journal-title":"Cutis"},{"key":"3384_CR28","doi-asserted-by":"publisher","unstructured":"A. Surve, C. Dhull, S.K. Khokhar, Metabolic Cataract BT - Atlas of Pediatric Cataract, in: S.K. Khokhar, C. Dhull (Eds.), Springer Singapore, Singapore, 2019: pp. 35\u201340. https:\/\/doi.org\/10.1007\/978-981-13-6939-1_3.","DOI":"10.1007\/978-981-13-6939-1_3"},{"key":"3384_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4103\/ijo.IJO_1091_18","volume":"67","author":"J Jinagal","year":"2019","unstructured":"Jinagal J, Gupta PC, Pilania RK, Ram J. Systemic toxicity of topical corticosteroids. Indian J Ophthalmol. 2019;67:559\u201361. https:\/\/doi.org\/10.4103\/ijo.IJO_1091_18.","journal-title":"Indian J Ophthalmol"},{"key":"3384_CR30","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/bjo.87.10.1247","volume":"87","author":"L Smeeth","year":"2003","unstructured":"Smeeth L, Boulis M, Hubbard R, Fletcher AE. A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthalmol. 2003;87:1247. https:\/\/doi.org\/10.1136\/bjo.87.10.1247.","journal-title":"Br J Ophthalmol"},{"key":"3384_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/jop.2006.0067","volume":"23","author":"ER James","year":"2007","unstructured":"James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther. 2007;23:403\u201320. https:\/\/doi.org\/10.1089\/jop.2006.0067.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3384_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.947659","volume":"9","author":"J Carlson","year":"2022","unstructured":"Carlson J, McBride K, O\u2019Connor M. Drugs associated with cataract formation represent an unmet need in cataract research. Front Med. 2022;9:947659. https:\/\/doi.org\/10.3389\/fmed.2022.947659.","journal-title":"Front Med"},{"key":"3384_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/ICL.0b013e31821cbcc9","volume":"37","author":"JE Roberts","year":"2011","unstructured":"Roberts JE. Ultraviolet radiation as a risk factor for cataract and macular degeneration. Eye & Contact Lens: Science & Clinical Practice. 2011;37:246\u20139. https:\/\/doi.org\/10.1097\/ICL.0b013e31821cbcc9.","journal-title":"Eye & Contact Lens: Science & Clinical Practice"},{"key":"3384_CR34","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1167\/iovs.14-14471","volume":"55","author":"C Delcourt","year":"2014","unstructured":"Delcourt C, Cougnard-Gr\u00e9goire A, Boniol M, Carri\u00e8re I, Dor\u00e9 JF, Delyfer MN, et al. Lifetime exposure to ambient ultraviolet radiation and the risk for cataract extraction and age-related macular degeneration: the alienor study. Investigative Opthalmology & Visual Science. 2014;55:7619\u201327. https:\/\/doi.org\/10.1167\/iovs.14-14471.","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"3384_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0140-6736(22)01839-6","volume":"401","author":"MV Cicinelli","year":"2023","unstructured":"Cicinelli MV, Buchan JC, Nicholson M, Varadaraj V, Khanna RC. Cataracts. Lancet. 2023;401:377\u201389.","journal-title":"Lancet"},{"key":"3384_CR36","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1080\/09553002.2020.1812759","volume":"96","author":"RB Richardson","year":"2020","unstructured":"Richardson RB, Ainsbury EA, Prescott CR, Lovicu FJ. Etiology of posterior subcapsular cataracts based on a review of risk factors including aging, diabetes, and ionizing radiation. Int J Radiat Biol. 2020;96:1339\u201361. https:\/\/doi.org\/10.1080\/09553002.2020.1812759.","journal-title":"Int J Radiat Biol"},{"key":"3384_CR37","doi-asserted-by":"publisher","unstructured":"T. Ikeda, M. Minami, K. Nakamura, T. Kida, M. Fukumoto, T. Sato, E. Ishizaki, Progression of nuclear sclerosis based on changes in refractive values after lens-sparing vitrectomy in proliferative diabetic retinopathy, Clin. Ophthalmol. (2014) 959\u2013963. https:\/\/doi.org\/10.2147\/opth.s61372.","DOI":"10.2147\/opth.s61372"},{"key":"3384_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4103\/2008-322X.170356","volume":"10","author":"BS Mamatha","year":"2015","unstructured":"Mamatha BS, Nidhi B, Padmaprabhu CA, Pallavi P, Vallikannan B. Risk factors for nuclear and cortical cataracts: a hospital based study. J Ophthalmic Vis Res. 2015;10:243. https:\/\/doi.org\/10.4103\/2008-322X.170356.","journal-title":"J Ophthalmic Vis Res"},{"key":"3384_CR39","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1016\/j.jcjo.2016.03.005","volume":"51","author":"RC Rao","year":"2016","unstructured":"Rao RC, Choudhry N. A christmas tree cataract. Can J Ophthalmol. 2016;51:e160\u20131.","journal-title":"Can J Ophthalmol"},{"key":"3384_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109083","volume":"219","author":"A Recchioni","year":"2022","unstructured":"Recchioni A, Mocciardini E, Ponzini E, Tavazzi S. Viscoelastic properties of the human tear film. Exp Eye Res. 2022;219:109083. https:\/\/doi.org\/10.1016\/j.exer.2022.109083.","journal-title":"Exp Eye Res"},{"key":"3384_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.addr.2017.09.008","volume":"126","author":"D Huang","year":"2018","unstructured":"Huang D, Chen Y-S, Rupenthal ID. Overcoming ocular drug delivery barriers through the use of physical forces. Adv Drug Deliv Rev. 2018;126:96\u2013112. https:\/\/doi.org\/10.1016\/j.addr.2017.09.008.","journal-title":"Adv Drug Deliv Rev"},{"key":"3384_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.51847\/TBlH98sXcQ","volume":"15","author":"SM Seethamraju","year":"2024","unstructured":"Seethamraju SM, Nori LP. Obstruction and approaches to cross the drug molecules through blood retinal barrier: an overview. Pharmacophore. 2024;15:20\u201332. https:\/\/doi.org\/10.51847\/TBlH98sXcQ.","journal-title":"Pharmacophore"},{"key":"3384_CR43","unstructured":"W.H. Organization, The global burden of disease: 2004 update, 2008. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/43942\/9789241563710_eng.pdf. Accessed 30 Sept 2022."},{"key":"3384_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/10715762.2013.777155","volume":"47","author":"R Thiagarajan","year":"2013","unstructured":"Thiagarajan R, Manikandan R. Antioxidants and cataract. Free Radic Res. 2013;47:337\u201345. https:\/\/doi.org\/10.3109\/10715762.2013.777155.","journal-title":"Free Radic Res"},{"key":"3384_CR45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/APO.0000000000000156","volume":"4","author":"S Cetinel","year":"2015","unstructured":"Cetinel S, Montemagno C. Nanotechnology for the prevention and treatment of cataract. Asia Pac J Ophthalmol. 2015;4:381\u20137. https:\/\/doi.org\/10.1097\/APO.0000000000000156.","journal-title":"Asia Pac J Ophthalmol"},{"key":"3384_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1006\/exer.2001.1049","volume":"73","author":"G Thiagarajan","year":"2001","unstructured":"Thiagarajan G, Chandani S, Sundari CS, Rao SH, Kulkarni AV, Balasubramanian D. Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract. Exp Eye Res. 2001;73:393\u2013401. https:\/\/doi.org\/10.1006\/exer.2001.1049.","journal-title":"Exp Eye Res"},{"key":"3384_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000063881","volume":"34","author":"SK Gupta","year":"2002","unstructured":"Gupta SK, Halder N, Srivastava S, Trivedi D, Joshi S, Varma SD. Green tea (Camellia sinensis) protects against selenite-induced oxidative stress in experimental cataractogenesis. Ophthalmic Res. 2002;34:258\u201363. https:\/\/doi.org\/10.1159\/000063881.","journal-title":"Ophthalmic Res"},{"key":"3384_CR48","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S0899-9007(03)00140-0","volume":"19","author":"SK Gupta","year":"2003","unstructured":"Gupta SK, Trivedi D, Srivastava S, Joshi S, Halder N, Verma SD. Lycopene attenuates oxidative stress induced experimental cataract development: an in vitro and in vivo study. Nutrition. 2003;19:794\u20139. https:\/\/doi.org\/10.1016\/S0899-9007(03)00140-0.","journal-title":"Nutrition"},{"key":"3384_CR49","first-page":"305","volume":"41","author":"M Khorsand","year":"2016","unstructured":"Khorsand M, Akmali M, Sharzad S, Beheshtitabar M. Melatonin reduces cataract formation and aldose reductase activity in lenses of streptozotocin-induced diabetic rat. Iran J Med Sci. 2016;41:305\u201313 ((accessed May 31, 2023)).","journal-title":"Iran J Med Sci"},{"key":"3384_CR50","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/02713680600899663","volume":"31","author":"R Ya\u01e7ci","year":"2006","unstructured":"Ya\u01e7ci R, Aydin B, Erdurmu\u015f M, Karada\u01e7 R, G\u00fcrel A, Durmu\u015f M, et al. Use of melatonin to prevent selenite-induced cataract formation in rat eyes. Curr Eye Res. 2006;31:845\u201350. https:\/\/doi.org\/10.1080\/02713680600899663.","journal-title":"Curr Eye Res"},{"key":"3384_CR51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijpharm.2009.01.001","volume":"372","author":"J Zhang","year":"2009","unstructured":"Zhang J, Wang S. Topical use of Coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect. Int J Pharm. 2009;372:66\u201375. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.01.001.","journal-title":"Int J Pharm"},{"key":"3384_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3109\/02713680903447884","volume":"35","author":"R Manikandan","year":"2010","unstructured":"Manikandan R, Thiagarajan R, Beulaja S, Sudhandiran G, Arumugam M. Effect of curcumin on selenite-induced cataractogenesis in wistar rat pups. Curr Eye Res. 2010;35:122\u20139. https:\/\/doi.org\/10.3109\/02713680903447884.","journal-title":"Curr Eye Res"},{"key":"3384_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078217","author":"CN Grama","year":"2013","unstructured":"Grama CN, Suryanarayana P, Patil MA, Raghu G, Balakrishna N, Ravi Kumar MNV, et al. Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0078217.","journal-title":"PLoS ONE"},{"key":"3384_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102696","author":"T Anand","year":"2021","unstructured":"Anand T, Anbukkarasi M, Thomas PA, Geraldine P. A comparison between plain eugenol and eugenol-loaded chitosan nanoparticles for prevention of in vitro selenite-induced cataractogenesis. J Drug Deliv Sci Technol. 2021. https:\/\/doi.org\/10.1016\/j.jddst.2021.102696.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3384_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111371","author":"L Zhao","year":"2021","unstructured":"Zhao L, Wang H, Du X. The therapeutic use of quercetin in ophthalmology: recent applications. Biomed Pharmacother. 2021. https:\/\/doi.org\/10.1016\/j.biopha.2021.111371.","journal-title":"Biomed Pharmacother"},{"key":"3384_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101407","author":"Q Lan","year":"2020","unstructured":"Lan Q, Di D, Wang S, Zhao Q, Gao Y, Chang D, et al. Chitosan-N-acetylcysteine modified HP-\u03b2-CD inclusion complex as a potential ocular delivery system for anti-cataract drug: quercetin. J Drug Deliv Sci Technol. 2020. https:\/\/doi.org\/10.1016\/j.jddst.2019.101407.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3384_CR57","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/fsn3.855","volume":"6","author":"M Koushki","year":"2018","unstructured":"Koushki M, Amiri-Dashatan N, Ahmadi N, Abbaszadeh H, Rezaei-Tavirani M. Resveratrol: a miraculous natural compound for diseases treatment. Food Sci Nutr. 2018;6:2473\u201390. https:\/\/doi.org\/10.1002\/fsn3.855.","journal-title":"Food Sci Nutr"},{"key":"3384_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ph16010026","volume":"16","author":"Q Chen","year":"2022","unstructured":"Chen Q, Gu P, Liu X, Hu S, Zheng H, Liu T, et al. Gold nanoparticles encapsulated resveratrol as an anti-aging agent to delay cataract development. Pharmaceuticals. 2022;16:26. https:\/\/doi.org\/10.3390\/ph16010026.","journal-title":"Pharmaceuticals"},{"key":"3384_CR59","doi-asserted-by":"publisher","unstructured":"X. Chen, Q. Xi, F. Sun, L. Zou, Y. Li, Facile fabrication of redox nanoparticles loaded with exosomal-miRNAs and resveratrol as glycation inhibitor in alleviating the progression and development of diabetic cataract, Naunyn. Schmiedebergs. Arch. Pharmacol. (2024) 1\u201317. https:\/\/doi.org\/10.1007\/s00210-024-03535-4.","DOI":"10.1007\/s00210-024-03535-4"},{"key":"3384_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13080955","volume":"13","author":"M Moldovan","year":"2023","unstructured":"Moldovan M, P\u0103puric\u0103 A-M, Muntean M, Bung\u0103rdean RM, Gheban D, Moldovan B, et al. Effects of gold nanoparticles phytoreduced with Rutin in an early rat model of diabetic retinopathy and cataracts. Metabolites. 2023;13:955. https:\/\/doi.org\/10.3390\/metabo13080955.","journal-title":"Metabolites"},{"key":"3384_CR61","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0014-4835(92)90129-G","volume":"54","author":"B Robert","year":"1992","unstructured":"Robert B, Harding JJ. Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen. Exp Eye Res. 1992;54:509\u201318. https:\/\/doi.org\/10.1016\/0014-4835(92)90129-G.","journal-title":"Exp Eye Res"},{"key":"3384_CR62","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.exer.2006.07.009","volume":"83","author":"P Geraldine","year":"2006","unstructured":"Geraldine P, Brijit Sneha B, Elanchezhian R, Ramesh E, Kalavathy CM, Kaliamurthy J, et al. Prevention of selenite-induced cataractogenesis by acetyl-l-carnitine: an experimental study. Exp Eye Res. 2006;83:1340\u20139. https:\/\/doi.org\/10.1016\/j.exer.2006.07.009.","journal-title":"Exp Eye Res"},{"key":"3384_CR63","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1248\/bpb.35.239","volume":"35","author":"N Nagai","year":"2012","unstructured":"Nagai N, Ito Y, Takeuchi N. Pharmacokinetic and pharmacodynamic evaluation of the anti-cataract effect of eye drops containing disulfiram and low-substituted methylcellulose using ICR\/f rats as a hereditary cataract model. Biol Pharm Bull. 2012;35:239\u201345. https:\/\/doi.org\/10.1248\/bpb.35.239.","journal-title":"Biol Pharm Bull"},{"key":"3384_CR64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.colsurfb.2017.08.037","volume":"160","author":"C Liu","year":"2017","unstructured":"Liu C, Lan Q, He W, Nie C, Zhang C, Xu T, et al. Octa-arginine modified lipid emulsions as a potential ocular delivery system for disulfiram: a study of the corneal permeation, transcorneal mechanism and anti-cataract effect. Colloids Surf, B. 2017;160:305\u201314. https:\/\/doi.org\/10.1016\/j.colsurfb.2017.08.037.","journal-title":"Colloids Surf, B"},{"key":"3384_CR65","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ajps.2018.02.010","volume":"13","author":"C Zhang","year":"2018","unstructured":"Zhang C, Xu T, Zhang D, He W, Wang S, Jiang T. Disulfiram thermosensitive in-situ gel based on solid dispersion for cataract. Asian J Pharm Sci. 2018;13:527\u201335. https:\/\/doi.org\/10.1016\/j.ajps.2018.02.010.","journal-title":"Asian J Pharm Sci"},{"key":"3384_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071520","volume":"14","author":"S Deguchi","year":"2022","unstructured":"Deguchi S, Kadowaki R, Otake H, Taga A, Nakazawa Y, Misra M, et al. Combination of lanosterol and nilvadipine nanosuspensions rescues lens opacification in selenite-induced cataractic rats. Pharmaceutics. 2022;14:1520. https:\/\/doi.org\/10.3390\/pharmaceutics14071520.","journal-title":"Pharmaceutics"},{"key":"3384_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13121999","volume":"13","author":"R Goto","year":"2021","unstructured":"Goto R, Yamada S, Otake H, Nakazawa Y, Oka M, Yamamoto N, et al. Instillation of ophthalmic formulation containing nilvadipine nanocrystals attenuates lens opacification in shumiya cataract rats. Pharmaceutics. 2021;13:1999. https:\/\/doi.org\/10.3390\/pharmaceutics13121999.","journal-title":"Pharmaceutics"},{"key":"3384_CR68","volume-title":"StatPearls[Internet]","author":"IS Padda","year":"2025","unstructured":"Padda IS, Mahtani AU, Parmar M. Sodium-Glucose Transport 2 (SGLT2) Inhibitors. In: StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Accessed 15 Sep 2025."},{"key":"3384_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122005","volume":"330","author":"Y-Y Chen","year":"2023","unstructured":"Chen Y-Y, Chen C-K, Wu T-T, Ho C-Y, Yeh T-C, Sun G-C, et al. Attenuation of epithelial-mesenchymal transition via SGLT2 inhibition and diabetic cataract suppression by dapagliflozin nanoparticles treatment. Life Sci. 2023;330:122005. https:\/\/doi.org\/10.1016\/j.lfs.2023.122005.","journal-title":"Life Sci"},{"key":"3384_CR70","first-page":"58","volume":"113","author":"G Davis","year":"2016","unstructured":"Davis G. The evolution of cataract surgery. Mo Med. 2016;113:58.","journal-title":"Mo Med"},{"key":"3384_CR71","unstructured":"Lindstrom R. Thoughts on cataract surgery: 2015, Rev Ophthalmol. https:\/\/www.reviewofophthalmology.com\/article\/thoughts-on--cataract-surgery-2015. Accessed 9 Mar 2015."},{"key":"3384_CR72","unstructured":"R. Lindstrom, Future of Cataract Surgery seems promising, Healio. (2021). https:\/\/www.healio.com\/news\/ophthalmology\/20210126\/future-of-cataract-surgery-seems-promising. Accessed 15 Aug 2023."},{"key":"3384_CR73","unstructured":"Duke-Elder S. System of ophthalmology. In: Vol XI: Diseases of the lens and vitreous; glaucoma and hypotony. St. Louis, MO: CV Mosby Co; 1969. p. 63.\u00a0https:\/\/www.abebooks.com\/first-edition\/System-Ophthalmology-Volume-Diseases-Lens-Vitreous\/30745560165\/bd"},{"key":"3384_CR74","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0886-3350(87)80131-1","volume":"13","author":"DJ Apple","year":"1987","unstructured":"Apple DJ, Brems RN, Park RB, Kavka-Van Norman D, Hansen SO, Tetz MR, et al. Anterior chamber lenses. Part I: complications and pathology and a review of designs. J Cataract Refract Surg. 1987;13:157\u201374. https:\/\/doi.org\/10.1016\/s0886-3350(87)80131-1.","journal-title":"J Cataract Refract Surg"},{"key":"3384_CR75","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1055\/s-2008-1045526","volume":"205","author":"M Blumenthal","year":"1994","unstructured":"Blumenthal M. Manual ECCE, the present state of the art. Klin Monbl Augenheilkd. 1994;205:266\u201370. https:\/\/doi.org\/10.1055\/s-2008-1045526.","journal-title":"Klin Monbl Augenheilkd"},{"key":"3384_CR76","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ophtha.2004.11.055","volume":"112","author":"PM Gogate","year":"2005","unstructured":"Gogate PM, Kulkarni SR, Krishnaiah S, Deshpande RD, Joshi SA, Palimkar A, et al. Safety and efficacy of phacoemulsification compared with manual small-incision cataract surgery by a randomized controlled clinical trial: six-week results. Ophthalmology. 2005;112:869\u201374. https:\/\/doi.org\/10.1016\/j.ophtha.2004.11.055.","journal-title":"Ophthalmology"},{"key":"3384_CR77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9394(67)93340-5","volume":"64","author":"K Cd","year":"1967","unstructured":"Cd K. Phaco-emulsification and aspiration; a new technique of cataract removal-a preliminary report. Am J Ophthalmol. 1967;64:23\u201335.","journal-title":"Am J Ophthalmol"},{"key":"3384_CR78","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1586\/eop.09.36","volume":"4","author":"MU Saeed","year":"2009","unstructured":"Saeed MU, Prasad S. Microincision cataract surgery: technology and techniques. Expert Rev Ophthalmol. 2009;4:505\u201313. https:\/\/doi.org\/10.1586\/eop.09.36.","journal-title":"Expert Rev Ophthalmol"},{"key":"3384_CR79","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.jcrs.2013.09.002","volume":"39","author":"K Donaldson","year":"2013","unstructured":"Donaldson K, Braga-Mele R, Donaldson KE, Cabot F, Davidson R, Dhaliwal DK, et al. Femtosecond laser\u2013assisted cataract surgery. J Cataract Refract Surg. 2013;39:1753\u201363. https:\/\/doi.org\/10.1016\/j.jcrs.2013.09.002.","journal-title":"J Cataract Refract Surg"},{"key":"3384_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/aos.13055","volume":"94","author":"S Porela-Tiihonen","year":"2016","unstructured":"Porela-Tiihonen S, Kokki H, Kaarniranta K, Kokki M. Recovery after cataract surgery. Acta Ophthalmol. 2016;94:1\u201334. https:\/\/doi.org\/10.1111\/aos.13055.","journal-title":"Acta Ophthalmol"},{"key":"3384_CR81","unstructured":"Nizami AA, Gurnani B, Gulani AC. Gulani. Cataract. [Updated 2024 Feb 27]. In: StatPearls [Internet]. Treasure Island(FL): StatPearls Publishing; 2025 Jan-.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539699\/"},{"key":"3384_CR82","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0140-6736(17)30544-5","volume":"390","author":"Y-C Liu","year":"2017","unstructured":"Liu Y-C, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017;390:600\u201312.","journal-title":"Lancet"},{"key":"3384_CR83","doi-asserted-by":"crossref","unstructured":"Gupta A, Bansal R, Sharma A, Kapil A. Macular Oedema. In Ophthalmic signs in practice of\u00a0Medicine. Singapore: Springer Nature Singapore;2024.\u00a0p. 271-317. https:\/\/www.scribd.com\/document\/991955961\/Ophthalmic-Signs-in-Practice-of-Medicine-Feb-14-2024-9819979226-Springer-1st-Edition-Gupta-eBook-instant-availability. Accessed 14 Feb 2024.","DOI":"10.1007\/978-981-99-7923-3_11"},{"key":"3384_CR84","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.survophthal.2009.07.005","volume":"55","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010;55:108\u201333. https:\/\/doi.org\/10.1016\/j.survophthal.2009.07.005.","journal-title":"Surv Ophthalmol"},{"key":"3384_CR85","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/1060028015574593","volume":"49","author":"DJ Wilson","year":"2015","unstructured":"Wilson DJ, Schutte SM, Abel SR. Comparing the efficacy of ophthalmic NSAIDs in common indications: a literature review to support cost-effective prescribing. Ann Pharmacother. 2015;49:727\u201334. https:\/\/doi.org\/10.1177\/1060028015574593.","journal-title":"Ann Pharmacother"},{"key":"3384_CR86","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0928-0987(02)00057-X","volume":"16","author":"R Pignatello","year":"2002","unstructured":"Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. Eudragit RS100\u00ae nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci. 2002;16:53\u201361. https:\/\/doi.org\/10.1016\/S0928-0987(02)00057-X.","journal-title":"Eur J Pharm Sci"},{"key":"3384_CR87","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/21691401.2021.1895184","volume":"49","author":"Y Xing","year":"2021","unstructured":"Xing Y, Zhu L, Zhang K, Li T, Huang S. Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation. Artif Cells Nanomedicine Biotechnol. 2021;49:308\u201316. https:\/\/doi.org\/10.1080\/21691401.2021.1895184.","journal-title":"Artif Cells Nanomedicine Biotechnol"},{"key":"3384_CR88","unstructured":"Sankar V, Harikrishnan V, Kalvarasariel B, Prasanth G, Kandasamy R, Muniswamy N. Nanoparticles for post cataract treatment. Intl J Biomed Pharma Sci. 2009;3.\u00a0https:\/\/www.researchgate.net\/profile\/V-Sankar-2\/publication\/268529960_Nanoparticles_for_Post_Cataract_Treatment\/links\/547036ef0cf24af340c09aa5\/Nanoparticles-for-Post-Cataract-Treatment.pdf?origin=scientificContributions"},{"key":"3384_CR89","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/s0886-3350(13)80220-9","volume":"21","author":"O Nishi","year":"1995","unstructured":"Nishi O, Nishi K, Yamada Y, Mizumoto Y. Effect of indomethacin-coated posterior chamber intraocular lenses on postoperative inflammation and posterior capsule opacification. J Cataract Refract Surg. 1995;21:574\u20138. https:\/\/doi.org\/10.1016\/s0886-3350(13)80220-9.","journal-title":"J Cataract Refract Surg"},{"issue":"Suppl 1","key":"3384_CR90","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0886-3350(96)80166-0","volume":"22","author":"O Nishi","year":"1996","unstructured":"Nishi O, Nishi K, Morita T, Tada Y, Shirasawa E, Sakanishi K. Effect of intraocular sustained release of indomethacin on postoperative inflammation and posterior capsule opacification. J Cataract Refract Surg. 1996;22(Suppl 1):806\u201310. https:\/\/doi.org\/10.1016\/S0886-3350(96)80166-0.","journal-title":"J Cataract Refract Surg"},{"key":"3384_CR91","doi-asserted-by":"crossref","unstructured":"P. Chollet, F. Malecaze, P. Le Toan, \u2026 H.L.-J. of C.&, U. 1996, Annexin V\u2014coated intraocular lenses, J.Cataract Refract. Surg. 22 (1996) 818\u2013824. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0886335096801684. Accessed 25 Oct 2022.","DOI":"10.1016\/S0886-3350(96)80168-4"},{"key":"3384_CR92","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000094626","volume":"220","author":"RC Siqueira","year":"2006","unstructured":"Siqueira RC, Ribeiro Filho E, Fialho SL, Lucena LR, Maia Filho A, Haddad A, et al. Pharmacokinetic and toxicity investigations of a new intraocular lens with a dexamethasone drug delivery system: a pilot study. Ophthalmologica. 2006;220:338\u201342. https:\/\/doi.org\/10.1159\/000094626.","journal-title":"Ophthalmologica"},{"key":"3384_CR93","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1755-3768.2008.01419.x","volume":"88","author":"M Kugelberg","year":"2010","unstructured":"Kugelberg M, Shafiei K, Van Der Ploeg I, Zetterstr\u00f6m C. Intraocular lens as a drug delivery system for dexamethasone. Acta Ophthalmol. 2010;88:241\u20134. https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01419.x.","journal-title":"Acta Ophthalmol"},{"key":"3384_CR94","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2013.01.007","volume":"167","author":"SR Chennamaneni","year":"2013","unstructured":"Chennamaneni SR, Mamalis C, Archer B, Oakey Z, Ambati BK. Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation. J Control Release. 2013;167:53\u20139. https:\/\/doi.org\/10.1016\/j.jconrel.2013.01.007.","journal-title":"J Control Release"},{"key":"3384_CR95","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ijpharm.2007.10.054","volume":"352","author":"S Eperon","year":"2008","unstructured":"Eperon S, Bossy-Nobs L, Petropoulos IK, Gurny R, Guex-Crosier Y. A biodegradable drug delivery system for the treatment of postoperative inflammation. Int J Pharm. 2008;352:240\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.10.054.","journal-title":"Int J Pharm"},{"key":"3384_CR96","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.exer.2008.10.016","volume":"88","author":"IM Wormstone","year":"2009","unstructured":"Wormstone IM, Wang L, Liu CSC. Posterior capsule opacification. Exp Eye Res. 2009;88:257\u201369. https:\/\/doi.org\/10.1016\/j.exer.2008.10.016.","journal-title":"Exp Eye Res"},{"key":"3384_CR97","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijpharm.2013.07.032","volume":"454","author":"W Zhang","year":"2013","unstructured":"Zhang W, Li X, Ye T, Chen F, Sun X, Kong J, et al. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. Int J Pharm. 2013;454:354\u201366. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.07.032.","journal-title":"Int J Pharm"},{"key":"3384_CR98","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/php.12322","volume":"90","author":"Q Wu","year":"2014","unstructured":"Wu Q, Guo D, Du Y, Liu D, Wang D, Bi H. UVB irradiation enhances TiO2 nanoparticle-induced disruption of calcium homeostasis in human lens epithelial cells. Photochem Photobiol. 2014;90:1324\u201331. https:\/\/doi.org\/10.1111\/php.12322.","journal-title":"Photochem Photobiol"},{"key":"3384_CR99","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.tiv.2013.09.015","volume":"27","author":"D Wang","year":"2013","unstructured":"Wang D, Guo D, Bi H, Wu Q, Tian Q, Du Y. Zinc oxide nanoparticles inhibit Ca2+-ATPase expression in human lens epithelial cells under UVB irradiation. Toxicol Vitro. 2013;27:2117\u201326. https:\/\/doi.org\/10.1016\/j.tiv.2013.09.015.","journal-title":"Toxicol Vitro"},{"key":"3384_CR100","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/jop.2012.0184","volume":"29","author":"X Huang","year":"2013","unstructured":"Huang X, Wang Y, Cai JP, Ma XY, Li Y, Cheng JW, et al. Sustained release of 5-fluorouracil from chitosan nanoparticles surface modified intra ocular lens to prevent posterior capsule opacification: an in vitro and in vivo study. J Ocul Pharmacol Ther. 2013;29:208\u201315. https:\/\/doi.org\/10.1089\/jop.2012.0184.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3384_CR101","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00417-008-1007-0","volume":"247","author":"H Liu","year":"2009","unstructured":"Liu H, Wu L, Fu S, Hou Y, Liu P, Cui H, et al. Polylactide-glycolic acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes. Graefes Arch Clin Exp Ophthalmol. 2009;247:801\u20137. https:\/\/doi.org\/10.1007\/s00417-008-1007-0.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3384_CR102","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.exer.2009.06.016","volume":"89","author":"SA Pot","year":"2009","unstructured":"Pot SA, Chandler HL, Colitz CMH, Bentley E, Dubielzig RR, Mosley TS, et al. Selenium functionalized intraocular lenses inhibit posterior capsule opacification in an ex vivo canine lens capsular bag assay. Exp Eye Res. 2009;89:728\u201334. https:\/\/doi.org\/10.1016\/j.exer.2009.06.016.","journal-title":"Exp Eye Res"},{"key":"3384_CR103","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/jop.2011.0196","volume":"28","author":"JL Davis","year":"2012","unstructured":"Davis JL, Yi NY, Salmon JH, Charlton AN, Colitz CMH, Gilger BC. Sustained-release celecoxib from incubated acrylic intraocular lenses suppresses lens epithelial cell growth in an ex vivo model of posterior capsule opacity. J Ocul Pharmacol Ther. 2012;28:359\u201368. https:\/\/doi.org\/10.1089\/jop.2011.0196.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3384_CR104","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.actbio.2021.11.018","volume":"138","author":"D Lu","year":"2022","unstructured":"Lu D, Han Y, Liu D, Chen S, Qie J, Qu J, et al. Centrifugally concentric ring-patterned drug-loaded polymeric coating as an intraocular lens surface modification for efficient prevention of posterior capsular opacification. Acta Biomater. 2022;138:327\u201341. https:\/\/doi.org\/10.1016\/j.actbio.2021.11.018.","journal-title":"Acta Biomater"},{"key":"3384_CR105","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bioactmat.2021.07.015","volume":"9","author":"X Zhang","year":"2022","unstructured":"Zhang X, Lai K, Li S, Wang J, Li J, Wang W, et al. Drug-eluting intraocular lens with sustained bromfenac release for conquering posterior capsular opacification. Bioact Mater. 2022;9:343\u201357. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.07.015.","journal-title":"Bioact Mater"},{"key":"3384_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80476-x","volume":"11","author":"T Yan","year":"2021","unstructured":"Yan T, Ma Z, Liu J, Yin N, Lei S, Zhang X, et al. Thermoresponsive genistein NLC-dexamethasone-moxifloxacin multi drug delivery system in lens capsule bag to prevent complications after cataract surgery. Sci Rep. 2021;11:181.","journal-title":"Sci Rep"},{"key":"3384_CR107","doi-asserted-by":"publisher","first-page":"9840","DOI":"10.1039\/d1ra00201e","volume":"11","author":"J Xia","year":"2021","unstructured":"Xia J, Lu D, Han Y, Wang J, Hong Y, Zhao P, et al. Facile multifunctional IOL surface modification via poly (PEGMA-co-GMA) grafting for posterior capsular opacification inhibition. RSC Adv. 2021;11:9840\u20138. https:\/\/doi.org\/10.1039\/d1ra00201e.","journal-title":"RSC Adv"},{"key":"3384_CR108","doi-asserted-by":"publisher","first-page":"8398","DOI":"10.1039\/d2tb01974d","volume":"10","author":"Y Hong","year":"2022","unstructured":"Hong Y, Zou H, Hu Y, Fei F, Liang L, Liu D, et al. Design of foldable, responsively drug-eluting polyacrylic intraocular lens bulk materials for prevention of postoperative complications. J Mater Chem B. 2022;10:8398\u2013406. https:\/\/doi.org\/10.1039\/d2tb01974d.","journal-title":"J Mater Chem B"},{"key":"3384_CR109","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/09205063.2020.1865691","volume":"32","author":"H Huang","year":"2021","unstructured":"Huang H, Zhu S, Liu D, Wen S, Lin Q. Antiproliferative drug-loaded multi-functionalized intraocular lens for reducing posterior capsular opacification. J Biomater Sci Polym Ed. 2021;32:735\u201348. https:\/\/doi.org\/10.1080\/09205063.2020.1865691.","journal-title":"J Biomater Sci Polym Ed"},{"key":"3384_CR110","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/sj.eye.6702615","volume":"22","author":"A Ad\u00e1n","year":"2008","unstructured":"Ad\u00e1n A, Casaroli-Marano RP, Gris O, Navarro R, Bitrian E, Pelegrin L, et al. Pathological findings in the lens capsules and intraocular lens in chronic pseudophakic endophthalmitis: an electron microscopy study. Eye. 2008;22:113\u20139. https:\/\/doi.org\/10.1038\/sj.eye.6702615.","journal-title":"Eye"},{"key":"3384_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s13659-025-00514-x","volume":"15","author":"SA Hamdy","year":"2025","unstructured":"Hamdy SA, Hatem S, Elosaily H, Hassan AGA-E, Elshimy R, Osman AH, et al. Therapeutic targeting of ocular diseases with emphasis on PI3K\/Akt, and OPRL pathways by Hedera helix L. saponins: a new approach for the treatment of Pseudomonas aeruginosa-induced bacterial keratitis. Nat Prod Bioprospect. 2025;15:30. https:\/\/doi.org\/10.1007\/s13659-025-00514-x.","journal-title":"Nat Prod Bioprospect"},{"key":"3384_CR112","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s0084-392x(08)70221-1","volume":"6","author":"FM Recchia","year":"2005","unstructured":"Recchia FM. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Evid Based Ophthalmol. 2005;6:201\u20132. https:\/\/doi.org\/10.1016\/s0084-392x(08)70221-1.","journal-title":"Evid Based Ophthalmol"},{"key":"3384_CR113","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/02713680802382971","volume":"33","author":"Y Tsuchiya","year":"2008","unstructured":"Tsuchiya Y, Kobayakawa S, Tsuji A, Tochikubo T. Preventive effect against post-cataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics. Curr Eye Res. 2008;33:868\u201375. https:\/\/doi.org\/10.1080\/02713680802382971.","journal-title":"Curr Eye Res"},{"key":"3384_CR114","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1016\/j.biomaterials.2009.06.047","volume":"30","author":"EM Anderson","year":"2009","unstructured":"Anderson EM, Noble ML, Garty S, Ma H, Bryers JD, Shen TT, et al. Sustained release of antibiotic from poly(2-hydroxyethyl methacrylate) to prevent blinding infections after cataract surgery. Biomaterials. 2009;30:5675\u201381. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.06.047.","journal-title":"Biomaterials"},{"key":"3384_CR115","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1166\/mex.2021.2040","volume":"11","author":"R Wu","year":"2021","unstructured":"Wu R, Huang Q, Zhou Z, Chen Y, Hu H, Wang F, et al. Nanoparticulate ophthalmic drug delivery of norfloxacin to prevent ocular infection after cataract surgery: evaluation in animal model. Mater Express. 2021;11:1402\u201311. https:\/\/doi.org\/10.1166\/mex.2021.2040.","journal-title":"Mater Express"},{"key":"3384_CR116","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.addr.2018.03.009","volume":"126","author":"TR Thrimawithana","year":"2018","unstructured":"Thrimawithana TR, Rupenthal ID, R\u00e4sch SS, Lim JC, Morton JD, Bunt CR. Drug delivery to the lens for the management of cataracts. Adv Drug Deliv Rev. 2018;126:185\u201394. https:\/\/doi.org\/10.1016\/j.addr.2018.03.009.","journal-title":"Adv Drug Deliv Rev"},{"key":"3384_CR117","doi-asserted-by":"publisher","unstructured":"V.D.P. Dubois, A. Bastawrous, N-acetylcarnosine (NAC) drops for age-related cataract, Cochrane Database Syst. Rev. 2017 (2017). \/https:\/\/doi.org\/10.1002\/14651858.CD009493.pub2.","DOI":"10.1002\/14651858.CD009493.pub2"},{"key":"3384_CR118","doi-asserted-by":"publisher","DOI":"10.1080\/19932820.2018.1500347","author":"L Wang","year":"2018","unstructured":"Wang L, Liu W, Huang X. An approach to revolutionize cataract treatment by enhancing drug probing through intraocular cell line. Libyan J Med. 2018. https:\/\/doi.org\/10.1080\/19932820.2018.1500347.","journal-title":"Libyan J Med"},{"key":"3384_CR119","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2147\/DDDT.S160524","volume":"12","author":"N Li","year":"2018","unstructured":"Li N, Han Z, Li L, Zhang B, Liu Z, Li J. The anti-cataract molecular mechanism study in selenium cataract rats for baicalin ophthalmic nanoparticles. Drug Des Devel Ther. 2018;12:1399\u2013411. https:\/\/doi.org\/10.2147\/DDDT.S160524.","journal-title":"Drug Des Devel Ther"},{"key":"3384_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106368","volume":"102","author":"A Hussein","year":"2024","unstructured":"Hussein A, El-Kayal M, Shamma RN, Awad HH, Younes NF. Optimizing nutraceutical-loaded trehalosomes in-situ gel for diabetic cataract management: comprehensive in vitro and in vivo evaluations. J Drug Deliv Sci Technol. 2024;102:106368. https:\/\/doi.org\/10.1016\/j.jddst.2024.106368.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3384_CR121","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00210-023-02588-1","volume":"397","author":"AM Devi","year":"2024","unstructured":"Devi AM, Sankeshi V, Ravali A, Bandaru S, Theendra VK, Sagurthi SR. Inhibitory effect of Nifedipine on aldose reductase delays cataract progression. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:161\u201371. https:\/\/doi.org\/10.1007\/s00210-023-02588-1.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3384_CR122","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1021\/acsbiomaterials.8b01089","volume":"5","author":"L Xu","year":"2019","unstructured":"Xu L, Qiu W-X, Liu W-L, Zhang C, Zou M-Z, Sun Y-X, et al. PLA\u2013PEG micelles loaded with a classic vasodilator for oxidative cataract prevention. ACS Biomater Sci Eng. 2019;5:407\u201312. https:\/\/doi.org\/10.1021\/acsbiomaterials.8b01089.","journal-title":"ACS Biomater Sci Eng"},{"key":"3384_CR123","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1021\/acs.molpharmaceut.2c00341","volume":"19","author":"N Li","year":"2022","unstructured":"Li N, Zhao Z, Ma H, Liu Y, Nwafor EO, Zhu S, et al. Optimization and characterization of low-molecular-weight chitosan-coated Baicalin mPEG-PLGA nanoparticles for the treatment of cataract. Mol Pharm. 2022;19:3831\u201345. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00341.","journal-title":"Mol Pharm"},{"key":"3384_CR124","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4270","author":"Y Budama-Kilinc","year":"2018","unstructured":"Budama-Kilinc Y, Cakir-Koc R, Kecel-Gunduz S, Kokcu Y, Bicak B, Mutlu H, et al. Novel NAC-loaded poly(lactide-coglycolide acid) nanoparticles for cataract treatment: preparation, characterization, evaluation of structure, cytotoxicity, and molecular docking studies. PeerJ. 2018. https:\/\/doi.org\/10.7717\/peerj.4270.","journal-title":"PeerJ"},{"key":"3384_CR125","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.nano.2016.12.021","volume":"13","author":"J Yang","year":"2017","unstructured":"Yang J, Gong X, Fang L, Fan Q, Cai L, Qiu X, et al. Potential of CeCl3@mSiO2 nanoparticles in alleviating diabetic cataract development and progression. Nanomedicine Nanotechnology, Biol Med. 2017;13:1147\u201355. https:\/\/doi.org\/10.1016\/j.nano.2016.12.021.","journal-title":"Nanomedicine Nanotechnology, Biol Med"},{"key":"3384_CR126","doi-asserted-by":"publisher","first-page":"13126","DOI":"10.1039\/c9nr02350j","volume":"11","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Li L, Li S, Li S, Zhao M, Zhou Q, et al. Autoregenerative redox nanoparticles as an antioxidant and glycation inhibitor for palliation of diabetic cataracts. Nanoscale. 2019;11:13126\u201338. https:\/\/doi.org\/10.1039\/c9nr02350j.","journal-title":"Nanoscale"},{"key":"3384_CR127","doi-asserted-by":"publisher","first-page":"16596","DOI":"10.1039\/c9ra01252d","volume":"9","author":"BI Hanafy","year":"2019","unstructured":"Hanafy BI, Cave GWV, Barnett Y, Pierscionek B. Ethylene glycol coated nanoceria protects against oxidative stress in human lens epithelium. RSC Adv. 2019;9:16596\u2013605. https:\/\/doi.org\/10.1039\/c9ra01252d.","journal-title":"RSC Adv"},{"key":"3384_CR128","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3109\/07388551.2015.1049510","volume":"36","author":"A Manayi","year":"2016","unstructured":"Manayi A, Abdollahi M, Raman T, Nabavi SF, Habtemariam S, Daglia M, et al. Lutein and cataract: from bench to bedside. Crit Rev Biotechnol. 2016;36:829\u201339. https:\/\/doi.org\/10.3109\/07388551.2015.1049510.","journal-title":"Crit Rev Biotechnol"},{"key":"3384_CR129","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.nano.2018.09.016","volume":"15","author":"E Bodoki","year":"2019","unstructured":"Bodoki E, Vostinaru O, Samoila O, Dinte E, Bodoki AE, Swetledge S, et al. Topical nanodelivery system of lutein for the prevention of selenite-induced cataract. Nanomedicine Nanotechnol Biol Med. 2019;15:188\u201397. https:\/\/doi.org\/10.1016\/j.nano.2018.09.016.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"3384_CR130","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1379-y","author":"D Vora","year":"2019","unstructured":"Vora D, Heruye S, Kumari D, Opere C, Chauhan H. Preparation, characterization and antioxidant evaluation of poorly soluble polyphenol-loaded nanoparticles for cataract treatment. AAPS PharmSciTech. 2019. https:\/\/doi.org\/10.1208\/s12249-019-1379-y.","journal-title":"AAPS PharmSciTech"},{"key":"3384_CR131","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbac021","volume":"5","author":"K Zhang","year":"2022","unstructured":"Zhang K, He W, Du Y, Zhou Y, Wu X, Zhu J, et al. Inhibitory effect of lanosterol on cataractous lens of cynomolgus monkeys using a subconjunctival drug release system. Precis Clin Med. 2022;5:pbac021. https:\/\/doi.org\/10.1093\/pcmedi\/pbac021.","journal-title":"Precis Clin Med"},{"key":"3384_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031048","author":"N Nagai","year":"2020","unstructured":"Nagai N, Fukuoka Y, Sato K, Otake H, Taga A, Oka M, et al. The intravitreal injection of lanosterol nanoparticles rescues lens structure collapse at an early stage in shumiya cataract rats. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21031048.","journal-title":"Int J Mol Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03384-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:51:56Z","timestamp":1780390316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03384-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":132,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3384"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03384-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"We affirm that this manuscript has not been published and is not currently submitted in this language or in any other languages.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"AI-assisted tools were used exclusively for language editing and improvement of clarity. No AI tools were used in the generation, analysis, or interpretation of scientific data. The authors take full responsibility for the content of this manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of AI Use"}}],"article-number":"173"}}